612 related articles for article (PubMed ID: 2845779)
1. Oral fluconazole as suppressive therapy of disseminated cryptococcosis in patients with acquired immunodeficiency syndrome.
Sugar AM; Saunders C
Am J Med; 1988 Oct; 85(4):481-9. PubMed ID: 2845779
[TBL] [Abstract][Full Text] [Related]
2. Oral fluconazole therapy for patients with acquired immunodeficiency syndrome and cryptococcosis: experience with 22 patients.
Stern JJ; Hartman BJ; Sharkey P; Rowland V; Squires KE; Murray HW; Graybill JR
Am J Med; 1988 Oct; 85(4):477-80. PubMed ID: 2845778
[TBL] [Abstract][Full Text] [Related]
3. Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. A randomized trial.
Larsen RA; Leal MA; Chan LS
Ann Intern Med; 1990 Aug; 113(3):183-7. PubMed ID: 2197908
[TBL] [Abstract][Full Text] [Related]
4. Clinical diversity of invasive cryptococcosis in AIDS patients from central China: report of two cases with review of literature.
Zhang Y; Cooper B; Gui X; Sherer R; Cao Q
BMC Infect Dis; 2019 Nov; 19(1):1003. PubMed ID: 31775716
[TBL] [Abstract][Full Text] [Related]
5. HIV-associated disseminated cryptococcosis-An unusual clinical and diagnostic picture with successful cure by single dose liposomal amphotericin B treatment.
Gupta C; Dogra P; Jain V; Kaur R; Sharma JB
Diagn Microbiol Infect Dis; 2024 Jun; 109(2):116217. PubMed ID: 38513558
[TBL] [Abstract][Full Text] [Related]
6. Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group.
Saag MS; Powderly WG; Cloud GA; Robinson P; Grieco MH; Sharkey PK; Thompson SE; Sugar AM; Tuazon CU; Fisher JF
N Engl J Med; 1992 Jan; 326(2):83-9. PubMed ID: 1727236
[TBL] [Abstract][Full Text] [Related]
7. Cryptococcal meningitis in the acquired immunodeficiency syndrome.
Panther LA; Sande MA
Semin Respir Infect; 1990 Jun; 5(2):138-45. PubMed ID: 2247708
[TBL] [Abstract][Full Text] [Related]
8. Invasive fungal infection by Cryptococcus neoformans var. grubii with bone marrow and meningeal involvement in a HIV-infected patient: a case report.
Vechi HT; Theodoro RC; de Oliveira AL; Gomes RMODS; Soares RDA; Freire MG; Bay MB
BMC Infect Dis; 2019 Mar; 19(1):220. PubMed ID: 30832607
[TBL] [Abstract][Full Text] [Related]
9. Management of cryptococcosis in non-HIV-related patients.
Yao Z; Liao W; Chen R
Med Mycol; 2005 May; 43(3):245-51. PubMed ID: 16010851
[TBL] [Abstract][Full Text] [Related]
10. Persistent Cryptococcus neoformans infection of the prostate after successful treatment of meningitis. California Collaborative Treatment Group.
Larsen RA; Bozzette S; McCutchan JA; Chiu J; Leal MA; Richman DD
Ann Intern Med; 1989 Jul; 111(2):125-8. PubMed ID: 2545124
[TBL] [Abstract][Full Text] [Related]
11. Itraconazole therapy for cryptococcal meningitis and cryptococcosis.
Denning DW; Tucker RM; Hanson LH; Hamilton JR; Stevens DA
Arch Intern Med; 1989 Oct; 149(10):2301-8. PubMed ID: 2552949
[TBL] [Abstract][Full Text] [Related]
12. Amphotericin B with or without flucytosine followed by fluconazole as primary therapy for cryptococcal meningitis in patients with AIDS.
Jaruratanasirikul S
Southeast Asian J Trop Med Public Health; 1996 Dec; 27(4):719-23. PubMed ID: 9253873
[TBL] [Abstract][Full Text] [Related]
13. Fluconazole Non-susceptible Cryptococcus neoformans, Relapsing/Refractory Cryptococcosis and Long-term Use of Liposomal Amphotericin B in an AIDS Patient.
de Carvalho Santana R; Schiave LA; Dos Santos Quaglio AS; de Gaitani CM; Martinez R
Mycopathologia; 2017 Oct; 182(9-10):855-861. PubMed ID: 28656554
[TBL] [Abstract][Full Text] [Related]
14. Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America.
Saag MS; Graybill RJ; Larsen RA; Pappas PG; Perfect JR; Powderly WG; Sobel JD; Dismukes WE
Clin Infect Dis; 2000 Apr; 30(4):710-8. PubMed ID: 10770733
[TBL] [Abstract][Full Text] [Related]
15. Overview: treatment of cryptococcal meningitis.
Sugar AM; Stern JJ; Dupont B
Rev Infect Dis; 1990; 12 Suppl 3():S338-48. PubMed ID: 2184512
[TBL] [Abstract][Full Text] [Related]
16. A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. The NIAID AIDS Clinical Trials Group and Mycoses Study Group.
Powderly WG; Saag MS; Cloud GA; Robinson P; Meyer RD; Jacobson JM; Graybill JR; Sugar AM; McAuliffe VJ; Follansbee SE
N Engl J Med; 1992 Mar; 326(12):793-8. PubMed ID: 1538722
[TBL] [Abstract][Full Text] [Related]
17. Response to therapy in patients with cryptococcosis and AIDS: Association with in vitro susceptibility to fluconazole.
Agudelo CA; Muñoz C; Ramírez A; Tobón AM; de Bedout Bact C; Cano LE; Restrepo A
Rev Iberoam Micol; 2015; 32(4):214-20. PubMed ID: 25637338
[TBL] [Abstract][Full Text] [Related]
18. Parenteral and oral fluconazole for acute cryptococcal meningitis in AIDS: experience with thirteen patients.
Stern JJ; Pietroski NA; Buckley RM; Braffman MN; Rinaldi MG
Ann Pharmacother; 1992; 26(7-8):876-82. PubMed ID: 1504391
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of fluconazole in cryptococcal meningitis.
Jones PD; Marriott D; Speed BR
Diagn Microbiol Infect Dis; 1989; 12(4 Suppl):235S-238S. PubMed ID: 2556240
[TBL] [Abstract][Full Text] [Related]
20. [Disseminated cryptococcosis in patients with AIDS. Clinical, microbiological, and immunological analysis of 51 patients].
Metta HA; Corti ME; Negroni R; Helou S; Arechavala A; Soto I; Villafañe MF; Muzzio E; Castello T; Esquivel P; Trione N
Rev Argent Microbiol; 2002; 34(3):117-23. PubMed ID: 12415893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
